Sarasota, FL -- (SBWIRE) -- 09/23/2016 -- The report covers forecast and analysis for the clinical trial imaging market on a global and regional level. According to the report, the global clinical trial imaging market was valued at approximately USD 731.9 million in 2015 and is expected to reach approximately USD 1,052.9 million by 2021, growing at a CAGR of around 6.30% between 2016 and 2021. The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the clinical trial imaging market on a global level.

Request Sample Report: http://atozresearch.com/global-clinical-trial-imaging-market-research-reports/#tabs-142-0-2

In order to give the users of this report a comprehensive view on the clinical trial imaging market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's five forces model for the clinical trial imaging market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The clinical trial imaging market is segmented on the basis of service and software. Service accounted for a large chunk of the global clinical trial imaging market in 2015. Software is another leading segment and it accounted for 35.2% share of total market in 2015. This growth is mainly attributed to high investment in R&D activities coupled with government support.

Based on technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others. The CT segment dominated the market with over 31.0% share of the total market in 2015. MRI, PET and ultrasound are also accounted for significant share owing to the increasing disabled and aging populations who are commonly diagnosed with different disease and other complications.

Browse detail report at: http://atozresearch.com/global-clinical-trial-imaging-market-research-reports/

Some of the key end-users of the clinical trial imaging market include biotech companies, pharmaceutical, research centers, hospitals and others. Among all end-users, pharmaceutical was the leading segment and it accounted for over 45.0% share of the total revenue generated in 2015. Biotech companies another key outlet of the market and expected to exhibit significant growth within the forecast period. This growth is mainly due to rising development in bio-pharmaceutical industries.

The study provides a decisive view on the clinical trial imaging market by segmenting the market based on product, technology, end user and region. Software and service are segments of product, where, Software is designed for clinical trial imaging. Services including operational imaging services, reader service, system and technology, design consulting. Various technologies in clinical imaging include echo, PET, MRI, x ray, CT, and ultrasound among others. MRI, CT, X-ray, ultrasound are the technologies having highest share in clinical trial imaging market. Different end users in this market are biotech companies, pharmaceuticals, research center, hospitals, diagnosis centers and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of clinical trials imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

Read Report TOC: http://atozresearch.com/global-clinical-trial-imaging-market-research-reports/#tabs-142-0-1

This report segments the global clinical trial imaging market as follows:

Clinical Trials Imaging Market: Product Segment Analysis

Service
Software

Clinical Trials Imaging Market: Technology Segment Analysis

X-ray
CT
MRI
PET
Echo
Ultrasound
Other technologies

Clinical Trials Imaging Market: End user Segment Analysis

Biotech companies
Pharmaceutical
Research centers
Hospitals
Other end users

Clinical trial imaging Market: Regional Segment Analysis

North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa